Home/Filings/4/0000950170-24-139793
4//SEC Filing

Zakrzewski Joseph S 4

Accession 0000950170-24-139793

CIK 0001880438other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 6:33 PM ET

Size

5.4 KB

Accession

0000950170-24-139793

Insider Transaction Report

Form 4
Period: 2024-12-19
Transactions
  • Award

    Common Stock

    2024-12-19+9,816135,015 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    405,880
Footnotes (2)
  • [F1]Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
  • [F2]These shares are held by Z3 Trust, for which the Reporting Person is a trustee.

Documents

1 file

Issuer

AN2 Therapeutics, Inc.

CIK 0001880438

Entity typeother

Related Parties

1
  • filerCIK 0001331852

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 6:33 PM ET
Size
5.4 KB